Recent Blog Posts
Cell Microsystems Raises $1.8 M to Expand Commercial Operations
In a filing with the U.S. Security and Exchange Commission, the company reported that 12 investors participated in the funding round, which required no minimum investment. CEO Gary Pace, Ph.D., J.D., said that Cell Microsystems would use the funding to build out its commercial team with support and manufacturing personnel,
Cloning Cells After Gene Editing in Genetic Applications
Cloning cells after gene editing is a labor-intensive process because of issues around cell viability, clonality and overall cell culture efficiency. In this webinar, Jacquelyn DuVall, PhD, lead for Cellular and Genomics Applications at Cell Microsystems, and William Buchser, PhD, assistant professor in the Department of Genetics at the Washington
Generate Viable and Stable Clonal Colonies Within Days, Not Months
Researchers conducting genome editing with delicate cell types know it can take months to produce stable clonal colonies, with most organizations indicating a two- to three-month turnaround time — even for robust cells. Cell Microsystem’s CellRaft AIR™ System offers a workflow that requires approximately four to five days to generate
